Where does Seegene, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Seegene, Inc. ranks #6,837 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Seegene, Inc. hold?

Seegene, Inc. holds 49 US utility patents granted between 2016 and 2025, spanning 12 technology areas.

What is Seegene, Inc.'s Innovation Score?

Seegene, Inc. has an Innovation Score of 47.4 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Seegene, Inc.'s patent grant rate increasing or decreasing?

Seegene, Inc.'s recent grant velocity is +47% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Seegene, Inc.'s patents?

Seegene, Inc.'s patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Seegene, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Seegene, Inc.

Q: What technology areas does Seegene, Inc. focus on?

Seegene, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 48 patents, ranking #98 of 2,502 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

USPTO PatentsView assignee record - 49 granted patents across 12 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Seegene ranks #6,837 of 49,997 tracked US assignees by granted-patent volume, with 49 patents across 12 technology areas.

#6,837
of 49,997 US assignees by volume: Top 19%
by Innovation Score (47.4/100): 17.1
avg claims per patent: +47%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6837 · Foreign Corporation #6,837 · 49 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-SMALL 49 grants
UPPER-Q #6,837/49,997
PHOTO-FINISH QlikTech Internation…
CPC-FOCUS C12Q · 12 areas
INNOV-PAR 47.4/100
CLAIMS-RICH 17.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +47% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: QlikTech International AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Seegene’s 47.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.5 pts (29%) Velocity 11.3 pts (24%) Breadth 12.2 pts (26%) Claim depth 10.3 pts (22%)

Qualcomm Incorporated · highest

85
Clean Power… · near

47
Electro Industries/G… · near

47
Health Research · near

47
Seegene · this assignee

47
Slayback Pharma · near

47
3D Lighting… · lowest

7

What this shows Seegene's Innovation Score is 47.4/100 (top 19% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Seegene?

Each dot is one of Seegene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Seegene’s own 17.1 claims/patent is at or below the 17.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Seegene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Seegene's grants concentrate

Seegene, Inc. is a focused PatentsView assignee: 12 CPC subclasses with 98% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2017 (7 grants) versus a trough of 2 in 2019. By volume, Seegene sits between QlikTech International AB and Switch, Ltd..

Seegene's three-year grant acceleration

Seegene, Inc. shows 17 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Qliktech Internat…

49
Reata Pharmaceuti…

49
Rimowa

49
Relievant Medsyst…

49
SKF Magnetic Mech…

49
Standard Cognition

49
Stmicroelectronic…

49
Switch

49
Seegene ◀

49

What this shows Seegene holds 49 patents at rank #6,834, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Seegene

By rank, the assignees closest to #6,834 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Seegene's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Seegene, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Seegene ranks #98 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (47 here).

Electro Industries/Gauge Tech 47 Slayback Pharma LLC 47 Clean Power Research, L.L.C. 47 Health Research, Inc. 47

Seegene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Seegene, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	3	6.1%
2017	7	14.3%
2018	5	10.2%
2019	2	4.1%
2020	5	10.2%
2021	3	6.1%
2022	7	14.3%
2023	6	12.2%
2024	4	8.2%
2025partial year	7	14.3%

Which technologies does Seegene, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 48

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 15

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

G06F - Electric Digital Data Processing 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 3

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 2

B03C - Magnetic OR Electrostatic Separation OF Solid Materials From Solid Materials OR FLUIDS; Separation BY High-voltage Electric Fields 2

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

G02B - Optical Elements, Systems OR Apparatus 1

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 1

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Seegene, Inc.'s patent record in context - here's where to go next.

Seegene, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 98% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #6,837 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Seegene, Inc. against QlikTech International AB, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 47.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.